Santhera Pharmaceuticals Announces the Appointment of Barbara A. Heller as Chief Financial Officer

May 03, 2005 02:00 ET | Source: Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

Attachments

Press release (PDF)

Press release (PDF)...

Recommended Reading

November 05, 2025 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Closes USD 13 Million Royalty Monetization Agreement

Pratteln, Switzerland, November 5, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, to support...
Read More
November 04, 2025 01:31 ET | Source: Santhera Pharmaceuticals Holding AG

Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

Ad hoc announcement pursuant to Art. 53 LR Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly...
Read More